Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique.
It is hypothesized that psoriasis may be caused by aberrant gene expression. In an effort to identify and clone psoriasis-specific genes, we compared gene expression in normal, tape-stripped (wounded), and psoriatic skin using the cDNA differential display technique. Four genes not previously described in psoriasis--connexin 26, a gap junction protein; squamous cell carcinoma antigen-1 (SCCA1), a serine protease inhibitor; and mitochondrial NAD subunits 5 and 6--were identified as having very high expression levels in psoriatic skin. In situ hybridizations showed that connexin 26 mRNA was expressed 10-fold higher in psoriatic and 4-fold higher in tape-stripped epidermis than in controls. SCCA1 showed a 40-fold increase in mRNA expression, whereas mitochondrial NAD5 and NAD6 expression was increased 10- and 20-fold, respectively, in psoriatic skin. Northern blots confirmed the increased expression of connexin 26, SCCA1, and NAD6 genes in psoriatic skin. Immunohistochemistry showed that connexin 26 protein was strongly expressed in spinous keratinocytes from psoriatic skin and chronic wounds, but was absent in normal epidermis. These studies demonstrate the usefulness of this approach for identifying genes that are conditionally expressed in growth-activated human skin.